Latest Market Research Reports cover the present scenario and the expected growth of the global intravascular ultrasound market for 2016-2020. In order to calculate the market size, the reports present a vendor landscape and a corresponding detailed analysis of the top three vendors operating in the market.

Intravascular Ultrasound (IYUS) Report is a diagnostic test that uses sound waves to see inside the blood vessels by providing a real time view.

It uses a tiny baton or transducer attached at the top of a thin tube, called catheter. The catheter can be inserted into an artery in the groin area and moved up to the heart. The other end of the tube is attached to a computerized electrocardiogram machine with a monitor. IYUS is also called intravascular echocardiography as it is a combination of echocardiography and cardiac catheterization.

Intravascular Ultrasound is different and much advanced from the conventional Duplex Ultrasound, which is done from outside the body by placing the transducer on the skin. IYUS is used to monitor the functioning of the heart and examining the structure. It can measure arteries, ventricles, valves and can measure the size of cavities.

The attached computer measures how the sound waves get reflected off the blood vessel, then it converts the sound waves into pictures. IVUS gives the health care provider a look at the patient's coronary arteries from inside.

IVUS is extensively used for any treatment of the heart. Whether for getting information about the heart or its blood vessels and to detect if the patient needs a heart surgery.Angiography can be used to get a general look at the coronary arteries but it is unable to show the walls of the arteries. On the other hand, IVUS images show the artery walls and can reveal cholesterol and fat deposits. Buildup of these deposits lead to high dangers of heart attack. IVUS helps in understanding how stents become clogged. This is called stent restenosis.

The current key players in the global IYUS market are Philips Volcano, Boston Scientific, GE Healthcare, and Siemens Healthineers. While other emerging vendors in the market are Avinger, Hitachi Aloka Medical America, Infraredx, Medtronic, Samsung Medison, Silicon Valley Medical Instruments, and St. Jude Medical.

These companies use IVUS primarily for optimization of the interventional technique, which means vessel sizing and stent sizing, diameter, and length, and then to determine hoe adequately was the stent deployed, which includes lesion coverage, stent expansion and apposition, and any edge injury. In order to determine the outcomes of IVUS use, companies have to examine the results of thousands of patients to truly show the differences in regard to stent thrombosis, restenosis, or results with percutaneous coronary intervention (PCI) in general. However, most of the companies believe that they have had better outcomes with IVUS use, though it is really not easy to prove.

IVUS is extensively used in laboratories, as it helps in making decisions to determine stent length, diameter, and the need for adjunct therapy, whether pretreatment of the lesion needs even more aggressive techniques, such as predilation using a cutting balloon or adjunctive treatment using rotational atherectomy. It provides an idea of how the lesion will behave at the time of direct stenting. If any adjunctive techniques are needed, that can be optimized as well, and could be made more efficient.

Experts believe that IVUS doesn't make any significant difference in the time consumption, if the lab is systematic with all the required set up and everyone is familiar with the equipment, it adds no more than 5 minutes to the procedure. However, what takes some time is the interpretation of the images. More often, the inexperienced staff has a low level of comfort when they face clinical uncertainty while using the new technique. But, if IVUS is made part of routine use, comfort level will be high and interpretation of the images will be uniform across the board.

Business Research shows that manufacturers are trying to advance in semiconductor technology to provide efficient power saving to IYUS devices.

Market Trends suggests that the use of Intravascular Ultrasound Industry is rising rapidly and a steady development in the equipment and procedure is facilitating growth in the IVUS market. Across the labs, technicians are using at least 50% pre and post IVUS.
IVUS adds a slight risk to the complications that arise due to angiography and catheterization. These risks may include reactions, breathing problems, blood clots, irregular heartbeat and damage to a heart valve or blood vessels. However, the tests are very safe when done by an experienced team. The catheter has to be handled carefully after the test or operation. A slight pressure is applied in the groin area of the patient for a few hours to prevent bleeding.

Author's Bio: 

Our aim is to provide the best industry and market research report to the seeker. Currently, Market Research Hub is a one stop destination for all industry reports & analysis. Check out recent report published on-
Global Intravascular Ultrasound Market Predicted to Grow at High Rate During 2016-2020